-
1
-
-
50049084370
-
Understanding and harnessing the graft-versus-leukaemia effect
-
Barrett AJ,. Understanding and harnessing the graft-versus-leukaemia effect. Br J Haematol 2008; 142: 877-888.
-
(2008)
Br J Haematol
, vol.142
, pp. 877-888
-
-
Barrett, A.J.1
-
3
-
-
62849091765
-
Bone marrow transplantation: New approaches to immunosuppression and management of acute graft-versus-host disease
-
Auletta JJ, Cooke KR,. Bone marrow transplantation: New approaches to immunosuppression and management of acute graft-versus-host disease. Curr Opin Pediatr 2009; 21: 30-38.
-
(2009)
Curr Opin Pediatr
, vol.21
, pp. 30-38
-
-
Auletta, J.J.1
Cooke, K.R.2
-
5
-
-
33746424373
-
Mesenchymal stem cells as trophic mediators
-
Caplan AI, Dennis JE,. Mesenchymal stem cells as trophic mediators. J Cell Biochem 2006; 98: 1076-1084.
-
(2006)
J Cell Biochem
, vol.98
, pp. 1076-1084
-
-
Caplan, A.I.1
Dennis, J.E.2
-
6
-
-
77955646193
-
Mesenchymal and haematopoietic stem cells form a unique bone marrow niche
-
Mendez-Ferrer S, Michurina TV, Ferraro F, et al. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 2010; 466: 829-834.
-
(2010)
Nature
, vol.466
, pp. 829-834
-
-
Mendez-Ferrer, S.1
Michurina, T.V.2
Ferraro, F.3
-
7
-
-
34447639255
-
Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells
-
Le Blanc K, Samuelsson H, Gustafsson B, et al. Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells. Leukemia 2007; 21: 1733-1738.
-
(2007)
Leukemia
, vol.21
, pp. 1733-1738
-
-
Le Blanc, K.1
Samuelsson, H.2
Gustafsson, B.3
-
8
-
-
84872144085
-
Mechanisms of mesenchymal stromal cell immunomodulation
-
English K,. Mechanisms of mesenchymal stromal cell immunomodulation. Immunol Cell Biol 2013; 91: 19-26.
-
(2013)
Immunol Cell Biol
, vol.91
, pp. 19-26
-
-
English, K.1
-
9
-
-
13544249606
-
Human mesenchymal stem cells modulate allogeneic immune cell responses
-
Aggarwal S, Pittenger MF,. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005; 105: 1815-1822.
-
(2005)
Blood
, vol.105
, pp. 1815-1822
-
-
Aggarwal, S.1
Pittenger, M.F.2
-
10
-
-
84868091993
-
Safety of cell therapy with mesenchymal stromal cells (SafeCell): A systematic review and meta-analysis of clinical trials
-
Lalu MM, McIntyre L, Pugliese C, et al. Safety of cell therapy with mesenchymal stromal cells (SafeCell): A systematic review and meta-analysis of clinical trials. PLoS One 2012; 7: e47559.
-
(2012)
PLoS One
, vol.7
, pp. e47559
-
-
Lalu, M.M.1
McIntyre, L.2
Pugliese, C.3
-
11
-
-
43049103438
-
Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: A phase II study
-
Le Blanc K, Frassoni F, Ball L, et al. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: A phase II study. Lancet 2008; 371: 1579-1586.
-
(2008)
Lancet
, vol.371
, pp. 1579-1586
-
-
Le Blanc, K.1
Frassoni, F.2
Ball, L.3
-
13
-
-
77953618997
-
Regenerative stromal cell therapy in allogeneic hematopoietic stem cell transplantation: Current impact and future directions
-
Auletta JJ, Cooke KR, Solchaga LA, et al. Regenerative stromal cell therapy in allogeneic hematopoietic stem cell transplantation: Current impact and future directions. Biol Blood Marrow Transplant 2010; 16: 891-906.
-
(2010)
Biol Blood Marrow Transplant
, vol.16
, pp. 891-906
-
-
Auletta, J.J.1
Cooke, K.R.2
Solchaga, L.A.3
-
14
-
-
84875468183
-
The mesenchymal stromal cells dilemma - Does a negative phase III trial of random donor mesenchymal stromal cells in steroid-resistant graft-versus-host disease represent a death knell or a bump in the road?
-
Galipeau J,. The mesenchymal stromal cells dilemma-Does a negative phase III trial of random donor mesenchymal stromal cells in steroid-resistant graft-versus-host disease represent a death knell or a bump in the road? Cytotherapy 2013; 15: 2-8.
-
(2013)
Cytotherapy
, vol.15
, pp. 2-8
-
-
Galipeau, J.1
-
15
-
-
79956121863
-
Mouse models of graft-versus-host disease: Advances and limitations
-
Schroeder MA, Dipersio JF,. Mouse models of graft-versus-host disease: Advances and limitations. Dis Model Mech 2011; 4: 318-333.
-
(2011)
Dis Model Mech
, vol.4
, pp. 318-333
-
-
Schroeder, M.A.1
Dipersio, J.F.2
-
16
-
-
17444379357
-
Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation
-
Le Blanc K, Ringden O,. Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2005; 11: 321-334.
-
(2005)
Biol Blood Marrow Transplant
, vol.11
, pp. 321-334
-
-
Le Blanc, K.1
Ringden, O.2
-
17
-
-
35448996504
-
Immunomodulation by mesenchymal stem cells and clinical experience
-
Le Blanc K, Ringden O,. Immunomodulation by mesenchymal stem cells and clinical experience. J Intern Med 2007; 262: 509-525.
-
(2007)
J Intern Med
, vol.262
, pp. 509-525
-
-
Le Blanc, K.1
Ringden, O.2
-
18
-
-
84860849630
-
The immune plasticity of mesenchymal stromal cells from mice and men: Concordances and discrepancies
-
Romieu-Mourez R, Coutu DL, Galipeau J,. The immune plasticity of mesenchymal stromal cells from mice and men: Concordances and discrepancies. Front Biosci (Elite Ed) 2012; 4: 824-837.
-
(2012)
Front Biosci (Elite Ed)
, vol.4
, pp. 824-837
-
-
Romieu-Mourez, R.1
Coutu, D.L.2
Galipeau, J.3
-
19
-
-
0038204193
-
Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide
-
Krampera M, Glennie S, Dyson J, et al. Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood 2003; 101: 3722-3729.
-
(2003)
Blood
, vol.101
, pp. 3722-3729
-
-
Krampera, M.1
Glennie, S.2
Dyson, J.3
-
20
-
-
0037093058
-
Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli
-
Di Nicola M, Carlo-Stella C, Magni M, et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002; 99: 3838-3843.
-
(2002)
Blood
, vol.99
, pp. 3838-3843
-
-
Di Nicola, M.1
Carlo-Stella, C.2
Magni, M.3
-
21
-
-
15944376184
-
Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells
-
Glennie S, Soeiro I, Dyson PJ, et al. Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells. Blood 2005; 105: 2821-2827.
-
(2005)
Blood
, vol.105
, pp. 2821-2827
-
-
Glennie, S.1
Soeiro, I.2
Dyson, P.J.3
-
22
-
-
17744365164
-
T cell responses to allogeneic human mesenchymal stem cells: Immunogenicity, tolerance, and suppression
-
Klyushnenkova E, Mosca JD, Zernetkina V, et al. T cell responses to allogeneic human mesenchymal stem cells: Immunogenicity, tolerance, and suppression. J Biomed Sci 2005; 12: 47-57.
-
(2005)
J Biomed Sci
, vol.12
, pp. 47-57
-
-
Klyushnenkova, E.1
Mosca, J.D.2
Zernetkina, V.3
-
23
-
-
38649105374
-
Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide
-
Ren G, Zhang L, Zhao X, et al. Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell 2008; 2: 141-150.
-
(2008)
Cell Stem Cell
, vol.2
, pp. 141-150
-
-
Ren, G.1
Zhang, L.2
Zhao, X.3
-
24
-
-
2942595706
-
Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation
-
Meisel R, Zibert A, Laryea M, et al. Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation. Blood 2004; 103: 4619-4621.
-
(2004)
Blood
, vol.103
, pp. 4619-4621
-
-
Meisel, R.1
Zibert, A.2
Laryea, M.3
-
25
-
-
0034978248
-
LPS antagonism reduces graft-versus-host disease and preserves graft-versus-leukemia activity after experimental bone marrow transplantation
-
Cooke KR, Gerbitz A, Crawford JM, et al. LPS antagonism reduces graft-versus-host disease and preserves graft-versus-leukemia activity after experimental bone marrow transplantation. J Clin Invest 2001; 107: 1581-1589.
-
(2001)
J Clin Invest
, vol.107
, pp. 1581-1589
-
-
Cooke, K.R.1
Gerbitz, A.2
Crawford, J.M.3
-
26
-
-
79959421443
-
Fibroblast growth factor-2 enhances expansion of human bone marrow-derived mesenchymal stromal cells without diminishing their immunosuppressive potential
-
Auletta JJ, Zale EA, Welter JF, et al. Fibroblast growth factor-2 enhances expansion of human bone marrow-derived mesenchymal stromal cells without diminishing their immunosuppressive potential. Stem Cells Int 2011; 2011: 235176.
-
(2011)
Stem Cells Int
, vol.2011
, pp. 235176
-
-
Auletta, J.J.1
Zale, E.A.2
Welter, J.F.3
-
27
-
-
77951146832
-
Secondary lymphoid organs contribute to, but are not required for the induction of graft-versus-host responses following allogeneic bone marrow transplantation: A shifting paradigm for T cell allo-activation
-
Silva IA, Olkiewicz K, Askew D, et al. Secondary lymphoid organs contribute to, but are not required for the induction of graft-versus-host responses following allogeneic bone marrow transplantation: A shifting paradigm for T cell allo-activation. Biol Blood Marrow Transplant 2010; 16: 598-611.
-
(2010)
Biol Blood Marrow Transplant
, vol.16
, pp. 598-611
-
-
Silva, I.A.1
Olkiewicz, K.2
Askew, D.3
-
28
-
-
66249088354
-
Transcriptional profiling of human mesenchymal stem cells transduced with reporter genes for imaging
-
Wang F, Dennis JE, Awadallah A, et al. Transcriptional profiling of human mesenchymal stem cells transduced with reporter genes for imaging. Physiol Genom 2009; 37: 23-34.
-
(2009)
Physiol Genom
, vol.37
, pp. 23-34
-
-
Wang, F.1
Dennis, J.E.2
Awadallah, A.3
-
29
-
-
84907535297
-
Donor CD4+ Foxp3+ regulatory T cells are necessary for post-transplantation cyclophosphamide-mediated protection against GVHD in mice
-
Ganguly S, Ross DB, Panoskaltsis-Mortari A, et al. Donor CD4+ Foxp3+ regulatory T cells are necessary for post-transplantation cyclophosphamide-mediated protection against GVHD in mice.- Blood 2014; 124: 2131-2141.
-
(2014)
Blood
, vol.124
, pp. 2131-2141
-
-
Ganguly, S.1
Ross, D.B.2
Panoskaltsis-Mortari, A.3
-
30
-
-
37649021448
-
Monitoring lymphocyte proliferation in vitro and in vivo with the intracellular fluorescent dye carboxyfluorescein diacetate succinimidyl ester
-
Quah BJ, Warren HS, Parish CR,. Monitoring lymphocyte proliferation in vitro and in vivo with the intracellular fluorescent dye carboxyfluorescein diacetate succinimidyl ester. Nat Protoc 2007; 2: 2049-2056.
-
(2007)
Nat Protoc
, vol.2
, pp. 2049-2056
-
-
Quah, B.J.1
Warren, H.S.2
Parish, C.R.3
-
31
-
-
79951841819
-
Concise review: Dissecting a discrepancy in the literature: Do mesenchymal stem cells support or suppress tumor growth?
-
Klopp AH, Gupta A, Spaeth E, et al. Concise review: Dissecting a discrepancy in the literature: Do mesenchymal stem cells support or suppress tumor growth? Stem Cells 2011; 29: 11-19.
-
(2011)
Stem Cells
, vol.29
, pp. 11-19
-
-
Klopp, A.H.1
Gupta, A.2
Spaeth, E.3
-
32
-
-
65549088148
-
3D cryo-imaging: A very high-resolution view of the whole mouse
-
Roy D, Steyer GJ, Gargesha M, et al. 3D cryo-imaging: A very high-resolution view of the whole mouse. Anat Rec (Hoboken) 2009; 292: 342-351.
-
(2009)
Anat Rec (Hoboken)
, vol.292
, pp. 342-351
-
-
Roy, D.1
Steyer, G.J.2
Gargesha, M.3
-
33
-
-
84859789527
-
Detection and quantification of fluorescent cell clusters in cryo-imaging
-
Steyer GJ, Dong F, Kanodia L, et al. Detection and quantification of fluorescent cell clusters in cryo-imaging. Int J Biomed Imaging 2012; 2012: 698413.
-
(2012)
Int J Biomed Imaging
, vol.2012
, pp. 698413
-
-
Steyer, G.J.1
Dong, F.2
Kanodia, L.3
-
34
-
-
55249127064
-
Flow cytometric analysis of cell division by dye dilution
-
Chapter 9:Unit 9 11
-
Lyons AB, Doherty KV,. Flow cytometric analysis of cell division by dye dilution. Curr Protoc Cytom 2004;Chapter 9:Unit 9 11.
-
(2004)
Curr Protoc Cytom
-
-
Lyons, A.B.1
Doherty, K.V.2
-
35
-
-
0032701975
-
IL-11 separates graft-versus-leukemia effects from graft-versus-host disease after bone marrow transplantation
-
Teshima T, Hill GR, Pan L, et al. IL-11 separates graft-versus-leukemia effects from graft-versus-host disease after bone marrow transplantation. J Clin Invest 1999; 104: 317-325.
-
(1999)
J Clin Invest
, vol.104
, pp. 317-325
-
-
Teshima, T.1
Hill, G.R.2
Pan, L.3
-
36
-
-
84891372385
-
Vorinostat plus tacrolimus and mycophenolate to prevent graft-versus-host disease after related-donor reduced-intensity conditioning allogeneic haemopoietic stem-cell transplantation: A phase 1/2 trial
-
Choi SW, Braun T, Chang L, et al. Vorinostat plus tacrolimus and mycophenolate to prevent graft-versus-host disease after related-donor reduced-intensity conditioning allogeneic haemopoietic stem-cell transplantation: A phase 1/2 trial. Lancet Oncol 2014; 15: 87-95.
-
(2014)
Lancet Oncol
, vol.15
, pp. 87-95
-
-
Choi, S.W.1
Braun, T.2
Chang, L.3
-
37
-
-
1642415712
-
Histone deacetylase inhibitor suberoylanilide hydroxamic acid reduces acute graft-versus-host disease and preserves graft-versus-leukemia effect
-
Reddy P, Maeda Y, Hotary K, et al. Histone deacetylase inhibitor suberoylanilide hydroxamic acid reduces acute graft-versus-host disease and preserves graft-versus-leukemia effect. Proc Natl Acad Sci USA 2004; 101: 3921-3926.
-
(2004)
Proc Natl Acad Sci USA
, vol.101
, pp. 3921-3926
-
-
Reddy, P.1
Maeda, Y.2
Hotary, K.3
-
38
-
-
0033566285
-
Keratinocyte growth factor separates graft-versus-leukemia effects from graft-versus-host disease
-
Krijanovski OI, Hill GR, Cooke KR, et al. Keratinocyte growth factor separates graft-versus-leukemia effects from graft-versus-host disease. Blood 1999; 94: 825-831.
-
(1999)
Blood
, vol.94
, pp. 825-831
-
-
Krijanovski, O.I.1
Hill, G.R.2
Cooke, K.R.3
-
39
-
-
0032717103
-
Differential roles of IL-1 and TNF-alpha on graft-versus-host disease and graft versus leukemia
-
Hill GR, Teshima T, Gerbitz A, et al. Differential roles of IL-1 and TNF-alpha on graft-versus-host disease and graft versus leukemia. J Clin Invest 1999; 104: 459-467.
-
(1999)
J Clin Invest
, vol.104
, pp. 459-467
-
-
Hill, G.R.1
Teshima, T.2
Gerbitz, A.3
-
40
-
-
0032128206
-
Interleukin-11 promotes T cell polarization and prevents acute graft-versus-host disease after allogeneic bone marrow transplantation
-
Hill GR, Cooke KR, Teshima T, et al. Interleukin-11 promotes T cell polarization and prevents acute graft-versus-host disease after allogeneic bone marrow transplantation. J Clin Invest 1998; 102: 115-123.
-
(1998)
J Clin Invest
, vol.102
, pp. 115-123
-
-
Hill, G.R.1
Cooke, K.R.2
Teshima, T.3
-
41
-
-
23044472871
-
In vivo analyses of early events in acute graft-versus-host disease reveal sequential infiltration of T-cell subsets
-
Beilhack A, Schulz S, Baker J, et al. In vivo analyses of early events in acute graft-versus-host disease reveal sequential infiltration of T-cell subsets. Blood 2005; 106: 1113-1122.
-
(2005)
Blood
, vol.106
, pp. 1113-1122
-
-
Beilhack, A.1
Schulz, S.2
Baker, J.3
-
42
-
-
1942489203
-
In vivo imaging of graft-versus-host-disease in mice
-
Panoskaltsis-Mortari A, Price A, Hermanson JR, et al. In vivo imaging of graft-versus-host-disease in mice. Blood 2004; 103: 3590-3598.
-
(2004)
Blood
, vol.103
, pp. 3590-3598
-
-
Panoskaltsis-Mortari, A.1
Price, A.2
Hermanson, J.R.3
-
43
-
-
22144473736
-
Human mesenchymal stem cells require monocyte-mediated activation to suppress alloreactive T cells
-
Groh ME, Maitra B, Szekely E, et al. Human mesenchymal stem cells require monocyte-mediated activation to suppress alloreactive T cells. Exp Hematol 2005; 33: 928-934.
-
(2005)
Exp Hematol
, vol.33
, pp. 928-934
-
-
Groh, M.E.1
Maitra, B.2
Szekely, E.3
-
44
-
-
84855361145
-
Regulation of immune responses by prostaglandin E2
-
Kalinski P,. Regulation of immune responses by prostaglandin E2. J Immunol 2012; 188: 21-28.
-
(2012)
J Immunol
, vol.188
, pp. 21-28
-
-
Kalinski, P.1
-
45
-
-
84872088799
-
The meaning, the sense and the significance: Translating the science of mesenchymal stem cells into medicine
-
Bianco P, Cao X, Frenette PS, et al. The meaning, the sense and the significance: Translating the science of mesenchymal stem cells into medicine. Nat Med 2013; 19: 35-42.
-
(2013)
Nat Med
, vol.19
, pp. 35-42
-
-
Bianco, P.1
Cao, X.2
Frenette, P.S.3
-
46
-
-
1442332442
-
Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential
-
Peister A, Mellad JA, Larson BL, et al. Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential. Blood 2004; 103: 1662-1668.
-
(2004)
Blood
, vol.103
, pp. 1662-1668
-
-
Peister, A.1
Mellad, J.A.2
Larson, B.L.3
-
47
-
-
53149095051
-
Isolation and characterization of mouse mesenchymal stem cells
-
Sung JH, Yang HM, Park JB, et al. Isolation and characterization of mouse mesenchymal stem cells. Transplant Proc 2008; 40: 2649-2654.
-
(2008)
Transplant Proc
, vol.40
, pp. 2649-2654
-
-
Sung, J.H.1
Yang, H.M.2
Park, J.B.3
-
48
-
-
84881092225
-
Immunological characterization of multipotent mesenchymal stromal cells. The International Society for Cellular Therapy (ISCT) working proposal
-
Krampera M, Galipeau J, Shi Y, et al. Immunological characterization of multipotent mesenchymal stromal cells. The International Society for Cellular Therapy (ISCT) working proposal. Cytotherapy 2013; 15: 1054-1061.
-
(2013)
Cytotherapy
, vol.15
, pp. 1054-1061
-
-
Krampera, M.1
Galipeau, J.2
Shi, Y.3
-
49
-
-
32044454701
-
Experimental models to study development and function of the human immune system in vivo
-
Legrand N, Weijer K, Spits H,. Experimental models to study development and function of the human immune system in vivo. J Immunol 2006; 176: 2053-2058.
-
(2006)
J Immunol
, vol.176
, pp. 2053-2058
-
-
Legrand, N.1
Weijer, K.2
Spits, H.3
-
50
-
-
33750559121
-
Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease
-
Yanez R, Lamana ML, Garcia-Castro J, et al. Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease. Stem Cells 2006; 24: 2582-2591.
-
(2006)
Stem Cells
, vol.24
, pp. 2582-2591
-
-
Yanez, R.1
Lamana, M.L.2
Garcia-Castro, J.3
-
51
-
-
34548118697
-
Mesenchymal stem cells of cord blood origin are effective at preventing but not treating graft-versus-host disease
-
Tisato V, Naresh K, Girdlestone J, et al. Mesenchymal stem cells of cord blood origin are effective at preventing but not treating graft-versus-host disease. Leukemia 2007; 21: 1992-1999.
-
(2007)
Leukemia
, vol.21
, pp. 1992-1999
-
-
Tisato, V.1
Naresh, K.2
Girdlestone, J.3
-
52
-
-
84876086426
-
Human mesenchymal stem cells suppress donor CD4(+) T cell proliferation and reduce pathology in a humanized mouse model of acute graft-versus-host disease
-
Tobin LM, Healy ME, English K, et al. Human mesenchymal stem cells suppress donor CD4(+) T cell proliferation and reduce pathology in a humanized mouse model of acute graft-versus-host disease. Clin Exp Immunol 2013; 172: 333-348.
-
(2013)
Clin Exp Immunol
, vol.172
, pp. 333-348
-
-
Tobin, L.M.1
Healy, M.E.2
English, K.3
-
53
-
-
33745076513
-
Antigen-presenting property of mesenchymal stem cells occurs during a narrow window at low levels of interferon-gamma
-
Chan JL, Tang KC, Patel AP, et al. Antigen-presenting property of mesenchymal stem cells occurs during a narrow window at low levels of interferon-gamma. Blood 2006; 107: 4817-4824.
-
(2006)
Blood
, vol.107
, pp. 4817-4824
-
-
Chan, J.L.1
Tang, K.C.2
Patel, A.P.3
-
54
-
-
49649106257
-
IFN-gamma activation of mesenchymal stem cells for treatment and prevention of graft versus host disease
-
Polchert D, Sobinsky J, Douglas G, et al. IFN-gamma activation of mesenchymal stem cells for treatment and prevention of graft versus host disease. Eur J Immunol 2008; 38: 1745-1755.
-
(2008)
Eur J Immunol
, vol.38
, pp. 1745-1755
-
-
Polchert, D.1
Sobinsky, J.2
Douglas, G.3
-
55
-
-
0026510367
-
Functional characterization of a hybrid human-mouse interferon gamma receptor: Evidence for species-specific interaction of the extracellular receptor domain with a putative signal transducer
-
Hemmi S, Merlin G, Aguet M,. Functional characterization of a hybrid human-mouse interferon gamma receptor: Evidence for species-specific interaction of the extracellular receptor domain with a putative signal transducer. Proc Natl Acad Sci USA 1992; 89: 2737-2741.
-
(1992)
Proc Natl Acad Sci USA
, vol.89
, pp. 2737-2741
-
-
Hemmi, S.1
Merlin, G.2
Aguet, M.3
-
56
-
-
80052487336
-
Mesenchymal stromal cell 'licensing': A multistep process
-
Krampera M,. Mesenchymal stromal cell 'licensing': A multistep process. Leukemia 2011; 25: 1408-1414.
-
(2011)
Leukemia
, vol.25
, pp. 1408-1414
-
-
Krampera, M.1
-
57
-
-
84893597804
-
Transplantation tolerance: From theory to clinic
-
Fuchs EJ,. Transplantation tolerance: From theory to clinic. Immunol Rev 2014; 258: 64-79.
-
(2014)
Immunol Rev
, vol.258
, pp. 64-79
-
-
Fuchs, E.J.1
-
58
-
-
84876509737
-
Concise review: Immunologic lessons from solid organ transplantation for stem cell-based therapies
-
Loewendorf A, Csete M,. Concise review: Immunologic lessons from solid organ transplantation for stem cell-based therapies. Stem Cells Transl Med 2013; 2: 136-142.
-
(2013)
Stem Cells Transl Med
, vol.2
, pp. 136-142
-
-
Loewendorf, A.1
Csete, M.2
-
60
-
-
84860433872
-
Tolerance and withdrawal of immunosuppressive drugs in patients given kidney and hematopoietic cell transplants
-
Scandling JD, Busque S, Dejbakhsh-Jones S, et al. Tolerance and withdrawal of immunosuppressive drugs in patients given kidney and hematopoietic cell transplants. Am J Transplant 2012; 12: 1133-1145.
-
(2012)
Am J Transplant
, vol.12
, pp. 1133-1145
-
-
Scandling, J.D.1
Busque, S.2
Dejbakhsh-Jones, S.3
-
61
-
-
84863229939
-
Chimerism and tolerance without GVHD or engraftment syndrome in HLA-mismatched combined kidney and hematopoietic stem cell transplantation
-
Leventhal J, Abecassis M, Miller J, et al. Chimerism and tolerance without GVHD or engraftment syndrome in HLA-mismatched combined kidney and hematopoietic stem cell transplantation. Sci Transl Med 2012; 4: 124ra128.
-
(2012)
Sci Transl Med
, vol.4
, pp. 124ra128
-
-
Leventhal, J.1
Abecassis, M.2
Miller, J.3
-
62
-
-
84907962259
-
Human bone marrow- and adipose tissue-derived mesenchymal stromal cells are immunosuppressive and in a humanized allograft rejection model
-
Roemeling-van Rhijn M, Khairoun M, Korevaar SS, et al. Human bone marrow- and adipose tissue-derived mesenchymal stromal cells are immunosuppressive and in a humanized allograft rejection model. J Stem Cell Res Ther 2013;(suppl 6): 20780.
-
(2013)
J Stem Cell Res Ther
, pp. 20780
-
-
Roemeling-Van Rhijn, M.1
Khairoun, M.2
Korevaar, S.S.3
-
63
-
-
79953813838
-
Effect of co-transplantation of mesenchymal stem cells and hematopoietic stem cells as compared to hematopoietic stem cell transplantation alone in renal transplantation to achieve donor hypo-responsiveness
-
Vanikar AV, Trivedi HL, Feroze A, et al. Effect of co-transplantation of mesenchymal stem cells and hematopoietic stem cells as compared to hematopoietic stem cell transplantation alone in renal transplantation to achieve donor hypo-responsiveness. Int Urol Nephrol 2011; 43: 225-232.
-
(2011)
Int Urol Nephrol
, vol.43
, pp. 225-232
-
-
Vanikar, A.V.1
Trivedi, H.L.2
Feroze, A.3
-
64
-
-
85027944424
-
The role of mesenchymal stromal cells in chronic transplant rejection after solid organ transplantation
-
Reinders ME, Rabelink TJ, de Fijter JW,. The role of mesenchymal stromal cells in chronic transplant rejection after solid organ transplantation. Curr Opin Organ Transplant 2013; 18: 44-50.
-
(2013)
Curr Opin Organ Transplant
, vol.18
, pp. 44-50
-
-
Reinders, M.E.1
Rabelink, T.J.2
De Fijter, J.W.3
-
65
-
-
77958087116
-
Prostaglandin E2 plays a key role in the immunosuppressive properties of adipose and bone marrow tissue-derived mesenchymal stromal cells
-
Yanez R, Oviedo A, Aldea M, et al. Prostaglandin E2 plays a key role in the immunosuppressive properties of adipose and bone marrow tissue-derived mesenchymal stromal cells. Exp Cell Res 2010; 316: 3109-3123.
-
(2010)
Exp Cell Res
, vol.316
, pp. 3109-3123
-
-
Yanez, R.1
Oviedo, A.2
Aldea, M.3
-
66
-
-
77951975599
-
Human umbilical cord mesenchymal stem cells hUC-MSCs exert immunosuppressive activities through a PGE2-dependent mechanism
-
Chen K, Wang D, Du WT, et al. Human umbilical cord mesenchymal stem cells hUC-MSCs exert immunosuppressive activities through a PGE2-dependent mechanism. Clin Immunol 2010; 135: 448-458.
-
(2010)
Clin Immunol
, vol.135
, pp. 448-458
-
-
Chen, K.1
Wang, D.2
Du, W.T.3
-
67
-
-
84884936600
-
Clonal analysis of multipotent stromal cells derived from CD271+ bone marrow mononuclear cells: Functional heterogeneity and different mechanisms of allosuppression
-
Kuci Z, Seiberth J, Latifi-Pupovci H, et al. Clonal analysis of multipotent stromal cells derived from CD271+ bone marrow mononuclear cells: Functional heterogeneity and different mechanisms of allosuppression. Haematologica 2013; 98: 1609-1616.
-
(2013)
Haematologica
, vol.98
, pp. 1609-1616
-
-
Kuci, Z.1
Seiberth, J.2
Latifi-Pupovci, H.3
-
68
-
-
15044348816
-
Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms
-
Rasmusson I, Ringden O, Sundberg B, et al. Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms. Exp Cell Res 2005; 305: 33-41.
-
(2005)
Exp Cell Res
, vol.305
, pp. 33-41
-
-
Rasmusson, I.1
Ringden, O.2
Sundberg, B.3
-
69
-
-
84885625516
-
Prostaglandin E2: A putative potency indicator of the immunosuppressive activity of human mesenchymal stem cells
-
Solchaga LA, Zale EA,. Prostaglandin E2: A putative potency indicator of the immunosuppressive activity of human mesenchymal stem cells. Am J Stem Cells 2012; 1: 138-145.
-
(2012)
Am J Stem Cells
, vol.1
, pp. 138-145
-
-
Solchaga, L.A.1
Zale, E.A.2
-
70
-
-
22544436066
-
Prostaglandin E2 induces FOXP3 gene expression and T regulatory cell function in human CD4+ T cells
-
Baratelli F, Lin Y, Zhu L, et al. Prostaglandin E2 induces FOXP3 gene expression and T regulatory cell function in human CD4+ T cells. J Immunol 2005; 175: 1483-1490.
-
(2005)
J Immunol
, vol.175
, pp. 1483-1490
-
-
Baratelli, F.1
Lin, Y.2
Zhu, L.3
-
71
-
-
69249227552
-
MSCs inhibit monocyte-derived DC maturation and function by selectively interfering with the generation of immature DCs: Central role of MSC-derived prostaglandin E2
-
Spaggiari GM, Abdelrazik H, Becchetti F, et al. MSCs inhibit monocyte-derived DC maturation and function by selectively interfering with the generation of immature DCs: Central role of MSC-derived prostaglandin E2. Blood 2009; 113: 6576-6583.
-
(2009)
Blood
, vol.113
, pp. 6576-6583
-
-
Spaggiari, G.M.1
Abdelrazik, H.2
Becchetti, F.3
-
72
-
-
0035876913
-
A role for TGF-beta in the generation and expansion of CD4+CD25+ regulatory T cells from human peripheral blood
-
Yamagiwa S, Gray JD, Hashimoto S, et al. A role for TGF-beta in the generation and expansion of CD4+CD25+ regulatory T cells from human peripheral blood. J Immunol 2001; 166: 7282-7289.
-
(2001)
J Immunol
, vol.166
, pp. 7282-7289
-
-
Yamagiwa, S.1
Gray, J.D.2
Hashimoto, S.3
-
73
-
-
61849123247
-
Cell contact, prostaglandin E(2) and transforming growth factor beta 1 play non-redundant roles in human mesenchymal stem cell induction of CD4+CD25(High) forkhead box P3+ regulatory T cells
-
English K, Ryan JM, Tobin L, et al. Cell contact, prostaglandin E(2) and transforming growth factor beta 1 play non-redundant roles in human mesenchymal stem cell induction of CD4+CD25(High) forkhead box P3+ regulatory T cells. Clin Exp Immunol 2009; 156: 149-160.
-
(2009)
Clin Exp Immunol
, vol.156
, pp. 149-160
-
-
English, K.1
Ryan, J.M.2
Tobin, L.3
-
74
-
-
84860413570
-
Xenogeneic immunosuppression of human umbilical cord mesenchymal stem cells in a major histocompatibility complex (MHC)-mismatched allogeneic acute graft-versus-host disease murine model
-
Juan G, Jie Y, Guofan C, et al. Xenogeneic immunosuppression of human umbilical cord mesenchymal stem cells in a major histocompatibility complex (MHC)-mismatched allogeneic acute graft-versus-host disease murine model. Eur J Haematol 2011.
-
(2011)
Eur J Haematol
-
-
Juan, G.1
Jie, Y.2
Guofan, C.3
-
75
-
-
33846025952
-
In vivo distribution of human adipose-derived mesenchymal stem cells in novel xenotransplantation models
-
Meyerrose TE, De Ugarte DA, Hofling AA, et al. In vivo distribution of human adipose-derived mesenchymal stem cells in novel xenotransplantation models. Stem Cells 2007; 25: 220-227.
-
(2007)
Stem Cells
, vol.25
, pp. 220-227
-
-
Meyerrose, T.E.1
De Ugarte, D.A.2
Hofling, A.A.3
-
76
-
-
67649171661
-
Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6
-
Lee RH, Pulin AA, Seo MJ, et al. Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell 2009; 5: 54-63.
-
(2009)
Cell Stem Cell
, vol.5
, pp. 54-63
-
-
Lee, R.H.1
Pulin, A.A.2
Seo, M.J.3
-
77
-
-
33845277598
-
Mesenchymal stem cells display coordinated rolling and adhesion behavior on endothelial cells
-
Ruster B, Gottig S, Ludwig RJ, et al. Mesenchymal stem cells display coordinated rolling and adhesion behavior on endothelial cells. Blood 2006; 108: 3938-3944.
-
(2006)
Blood
, vol.108
, pp. 3938-3944
-
-
Ruster, B.1
Gottig, S.2
Ludwig, R.J.3
-
78
-
-
84902574385
-
CCR7 guides migration of mesenchymal stem cell to secondary lymphoid organs: A novel approach to separate GvHD from GvL effect
-
Li H, Jiang Y, Jiang X, et al. CCR7 guides migration of mesenchymal stem cell to secondary lymphoid organs: A novel approach to separate GvHD from GvL effect. Stem Cells 32: 1890-1903.
-
Stem Cells
, vol.32
, pp. 1890-1903
-
-
Li, H.1
Jiang, Y.2
Jiang, X.3
-
79
-
-
84863755249
-
Mesenchymal stromal cells for the treatment of graft-versus-host disease: Understanding the in vivo biological effect through patient immune monitoring
-
Dander E, Lucchini G, Vinci P, et al. Mesenchymal stromal cells for the treatment of graft-versus-host disease: Understanding the in vivo biological effect through patient immune monitoring. Leukemia 2012; 26: 1681-1684.
-
(2012)
Leukemia
, vol.26
, pp. 1681-1684
-
-
Dander, E.1
Lucchini, G.2
Vinci, P.3
-
80
-
-
45149085724
-
Third party mesenchymal stromal cell infusions fail to induce tissue repair despite successful control of severe grade IV acute graft-versus-host disease in a child with juvenile myelo-monocytic leukemia
-
Ball L, Bredius R, Lankester A, et al. Third party mesenchymal stromal cell infusions fail to induce tissue repair despite successful control of severe grade IV acute graft-versus-host disease in a child with juvenile myelo-monocytic leukemia. Leukemia 2008; 22: 1256-1257.
-
(2008)
Leukemia
, vol.22
, pp. 1256-1257
-
-
Ball, L.1
Bredius, R.2
Lankester, A.3
-
81
-
-
67349204472
-
Repair of tissues by adult stem/progenitor cells (MSCs): Controversies, myths, and changing paradigms
-
Prockop DJ,. Repair of tissues by adult stem/progenitor cells (MSCs): Controversies, myths, and changing paradigms. Mol Ther 2009; 17: 939-946.
-
(2009)
Mol Ther
, vol.17
, pp. 939-946
-
-
Prockop, D.J.1
-
82
-
-
0242410394
-
Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals
-
Djouad F, Plence P, Bony C, et al. Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood 2003; 102: 3837-3844.
-
(2003)
Blood
, vol.102
, pp. 3837-3844
-
-
Djouad, F.1
Plence, P.2
Bony, C.3
-
83
-
-
84881188594
-
Human mesenchymal stem cells creating an immunosuppressive environment and promote breast cancer in mice
-
Ljujic B, Milovanovic M, Volarevic V, et al. Human mesenchymal stem cells creating an immunosuppressive environment and promote breast cancer in mice. Sci Rep 2013; 3: 2298.
-
(2013)
Sci Rep
, vol.3
, pp. 2298
-
-
Ljujic, B.1
Milovanovic, M.2
Volarevic, V.3
-
84
-
-
40749112327
-
The correlation between cotransplantation of mesenchymal stem cells and higher recurrence rate in hematologic malignancy patients: Outcome of a pilot clinical study
-
Ning H, Yang F, Jiang M, et al. The correlation between cotransplantation of mesenchymal stem cells and higher recurrence rate in hematologic malignancy patients: Outcome of a pilot clinical study. Leukemia. 2008; 22: 593-599.
-
(2008)
Leukemia.
, vol.22
, pp. 593-599
-
-
Ning, H.1
Yang, F.2
Jiang, M.3
-
85
-
-
84881013788
-
Reduced efficacy of mesenchymal stromal cells in preventing graft-versus-host disease in an in vivo model of haploidentical bone marrow transplant with leukemia
-
Oviedo A, Yanez R, Colmenero I, et al. Reduced efficacy of mesenchymal stromal cells in preventing graft-versus-host disease in an in vivo model of haploidentical bone marrow transplant with leukemia. Cell Transplant 2013; 22: 1381-1394.
-
(2013)
Cell Transplant
, vol.22
, pp. 1381-1394
-
-
Oviedo, A.1
Yanez, R.2
Colmenero, I.3
-
86
-
-
68449086888
-
HSCT recipients have specific tolerance to MSC but not to the MSC donor
-
Sundin M, Barrett AJ, Ringden O, et al. HSCT recipients have specific tolerance to MSC but not to the MSC donor. J Immunother 2009; 32: 755-764.
-
(2009)
J Immunother
, vol.32
, pp. 755-764
-
-
Sundin, M.1
Barrett, A.J.2
Ringden, O.3
-
87
-
-
80053422428
-
Coinfusion of mesenchymal stromal cells facilitates platelet recovery without increasing leukemia recurrence in haploidentical hematopoietic stem cell transplantation: A randomized, controlled clinical study
-
Liu K, Chen Y, Zeng Y, et al. Coinfusion of mesenchymal stromal cells facilitates platelet recovery without increasing leukemia recurrence in haploidentical hematopoietic stem cell transplantation: A randomized, controlled clinical study. Stem Cells Dev 2011; 20: 1679-1685.
-
(2011)
Stem Cells Dev
, vol.20
, pp. 1679-1685
-
-
Liu, K.1
Chen, Y.2
Zeng, Y.3
-
88
-
-
77952584405
-
Cotransplantation of mesenchymal stem cells might prevent death from graft-versus-host disease (GVHD) without abrogating graft-versus-tumor effects after HLA-mismatched allogeneic transplantation following nonmyeloablative conditioning
-
Baron F, Lechanteur C, Willems E, et al. Cotransplantation of mesenchymal stem cells might prevent death from graft-versus-host disease (GVHD) without abrogating graft-versus-tumor effects after HLA-mismatched allogeneic transplantation following nonmyeloablative conditioning. Biol Blood Marrow Transplant 2010; 16: 838-847.
-
(2010)
Biol Blood Marrow Transplant
, vol.16
, pp. 838-847
-
-
Baron, F.1
Lechanteur, C.2
Willems, E.3
-
89
-
-
84885099905
-
Mesenchymal stromal cells: Sensors and switchers of inflammation
-
Bernardo ME, Fibbe WE,. Mesenchymal stromal cells: Sensors and switchers of inflammation. Cell Stem Cell 2013; 13: 392-402.
-
(2013)
Cell Stem Cell
, vol.13
, pp. 392-402
-
-
Bernardo, M.E.1
Fibbe, W.E.2
-
90
-
-
84856973179
-
Mesenchymal stem/stromal cells (MSCs): Role as guardians of inflammation
-
Prockop DJ, Oh JY,. Mesenchymal stem/stromal cells (MSCs): Role as guardians of inflammation. Mol Ther 2012; 20: 14-20.
-
(2012)
Mol Ther
, vol.20
, pp. 14-20
-
-
Prockop, D.J.1
Oh, J.Y.2
-
91
-
-
84896727247
-
IDO-independent suppression of T cell effector function by IFN-gamma-licensed human mesenchymal stromal cells
-
Chinnadurai R, Copland IB, Patel SR, et al. IDO-independent suppression of T cell effector function by IFN-gamma-licensed human mesenchymal stromal cells. J Immunol 2014; 192: 1491-1501.
-
(2014)
J Immunol
, vol.192
, pp. 1491-1501
-
-
Chinnadurai, R.1
Copland, I.B.2
Patel, S.R.3
-
92
-
-
5044220930
-
IDO expression by dendritic cells: Tolerance and tryptophan catabolism
-
Mellor AL, Munn DH,. IDO expression by dendritic cells: Tolerance and tryptophan catabolism. Nat Rev Immunol 2004; 4: 762-774.
-
(2004)
Nat Rev Immunol
, vol.4
, pp. 762-774
-
-
Mellor, A.L.1
Munn, D.H.2
-
93
-
-
84859860935
-
Tissue engineered regeneration of completely transected spinal cord using human mesenchymal stem cells
-
Kang KN, Kim da Y, Yoon SM, et al. Tissue engineered regeneration of completely transected spinal cord using human mesenchymal stem cells. Biomaterials 2012; 33: 4828-4835.
-
(2012)
Biomaterials
, vol.33
, pp. 4828-4835
-
-
Kang, K.N.1
Kim Da, Y.2
Yoon, S.M.3
-
94
-
-
84868523104
-
Mesenchymal stem cells are injured by complement after their contact with serum
-
Li Y, Lin F,. Mesenchymal stem cells are injured by complement after their contact with serum. Blood 2012; 120: 3436-3443.
-
(2012)
Blood
, vol.120
, pp. 3436-3443
-
-
Li, Y.1
Lin, F.2
|